NAVINTA LLC FDA Approval ANDA 206071

ANDA 206071

NAVINTA LLC

FDA Drug Application

Application #206071

Documents

Letter2017-11-27

Application Sponsors

ANDA 206071NAVINTA LLC

Marketing Status

Prescription001

Application Products

001SOLUTION;IM-IV1GM/10ML (100MG/ML)0METHOCARBAMOLMETHOCARBAMOL

FDA Submissions

UNKNOWN; ORIG1AP2017-11-24STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

NAVINTA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206071
            [companyName] => NAVINTA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHOCARBAMOL","activeIngredients":"METHOCARBAMOL","strength":"1GM\/10ML (100MG\/ML)","dosageForm":"SOLUTION;IM-IV","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/24\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/206071Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-11-24
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.